Each 5mg tablet contains 5mg Oxybutynin hydrochloride. Excipient(s) with known effect: Contains 106.50 mg Lactose monohydrate per tablet. For the full list of excipient, see section 6.1. Pinkstinks is a campaign that targets the products, media and marketing that prescribe heavily stereotyped and limiting roles to young girls. We believe that all children – girls and boys - are affected by the ‘pinkification’ of girlhood. Oxybutynin immediate-release oral tablet is available in a generic version only. The extended-release oral tablet is available as a generic and a brand-name drug. Oxybutynin is indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria). Oxybutynin chloride steady-state pharmacokinetics were also studied in 11 pediatric patients with detrusor overactivity associated with a neurological condition (e.g., spina bifida). INDICATIONS. DITROPAN XL ® (oxybutynin chloride) is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin reduces muscle spasms of the bladder and urinary tract. Oxybutynin is used to treat symptoms of overactive bladder, such as frequent or urgent urination, incontinence (urine leakage), and increased night-time urination. Each transdermal patch contains 36 mg of oxybutynin. The area of the patch is 39 cm 2, releasing a nominal 3.9 mg of oxybutynin per 24 hours. For a full list of excipients, see section 6.1. Cyclobenzaprine can cause various harmful side effects. MedlinePlus says that it can cause chest pain, convulsions, seizures, trouble breathing and dysphagia (trouble swallowing). Oxybutynin (Ditropan) is used to treat overactive bladder, a condition where the bladder muscles contract uncontrollably and cause the urgent need to urinate frequently.